Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000567915

Apexbio Technology LLC Urotensin-II-114-124-human-TFA
SDP

Catalog No. 5000567915
Encompass_Preferred

Urotensin II (114-124 human) TFA (CAS No 251293-28-4) is a peptide fragment primarily utilized in cardiovascular and neurological research It originates from human urotensin II a potent vasoactive peptide involved in various physiological processes primarily acting through the G protein-coupled urotensin II receptor (UT) This interaction influences cellular pathways related to vasoconstriction and vascular smooth muscle proliferation In vitro this fragment functions in the nanomolar to low micromolar range demonstrating significant potency in cellular assays Typically employed in cell models and animal studies it aids in exploring cardiovascular dysfunction evaluating potential therapeutic agents and drug screening protocols Experimental concentrations typically depend on the specific research design ensuring flexibility for diverse investigative focuses

Catalog No. 50-005-67915 Supplier Apexbio Technology LLC Supplier No. C86825
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Urotensin II (114-124 human) TFA (CAS No 251293-28-4) is a peptide fragment primarily utilized in cardiovascular and neurological research It originates from human urotensin II a potent vasoactive peptide involved in various physiological processes primarily acting through the G protein-coupled urotensin II receptor (UT) This interaction influences cellular pathways related to vasoconstriction and vascular smooth muscle proliferation In vitro this fragment functions in the nanomolar to low micromolar range demonstrating significant potency in cellular assays Typically employed in cell models and animal studies it aids in exploring cardiovascular dysfunction evaluating potential therapeutic agents and drug screening protocols Experimental concentrations typically depend on the specific research design ensuring flexibility for diverse investigative focuses

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.